The WHO defines obesity as an abnormal or excessive accumulation of body fat that may impair health. Obesity should be suspected when weight increases more rapidly than height; weight-for-height charts are the clinician’s primary tool. The WHO defines overweight as a BMI ab [....] » Read More
Objective: To evaluate the impact of continuous glucose monitoring (CGM)-guided behavioral interventions on glycemic control, metabolic parameters, and behavioral outcomes in individuals with prediabetes and obesity. Design: Systematic review and meta-analysis. Data sourc [....] » Read More
Obesity is a major global public health challenge and a primary driver of metabolic disorders, particularly type 2 diabetes mellitus (T2DM). The rising prevalence of obesity has contributed significantly to the global diabetes epidemic, especially in low- and middle-income countr [....] » Read More
Background: Metabolic Syndrome (MetS) is a non-communicable disorder caused by impaired management and storage of energy, primarily caused by unhealthy diets, sedentary lifestyle and stress. It is diagnosed when an individual exhibits any three of the following: obesity or i [....] » Read More
Introduction: Tibial plateau fractures (TPF) are high-energy fractures that often require surgery for proper healing. Literature identifies high body mass index (BMI) as a risk factor for poor surgical outcomes. This study aims to better understand how BMI affects outcomes after [....] » Read More
Introduction: GLP-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide have demonstrated significant efficacy in weight reduction and metabolic improvement. However, emerging data suggest that up to 45% of weight loss with semaglutide may derive from fat-free [....] » Read More
Title : Challenges of obesity in the geriatric population
Hassan Massoud Heshmati, Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research, United States
Will be Updated Soon...
Title : Eating patterns vs pharmacological treatment impacting obesity: A case study approach
Daryle Wane, Nurse Consultant, United States
In today’s world, we are all impacted by how policies affect our nutritional status in terms of food development, processing, lifestyle choices, environment, and genetics. Exploration of EBP resources will help to serve as a framework for discussion for future practice mana [....] » Read More
Title : Atypical anorexia is not that atypical eating disorders and obesity, the patient and clinician perspectives
Kelly Broadwater, Chrysalis Center for Counseling and Eating Disorder Treatment, United States
The majority of people with eating disorders (ED) are of higher-weight yet EDs are minimized, underreported and often go untreated in these individuals. These individuals are half as likely to receive a clinical diagnosis of an eating disorder from a health care practitioner as t [....] » Read More
Title : Atypical anorexia Is not that atypical: Eating disorders and obesity – The patient and clinician perspectives
Melinda J Watman , President & Founder of Weighty Decision, United States
The majority of people with eating disorders (ED) are of higher-weight yet EDs are minimized, underreported and often go untreated in these individuals. These individuals are half as likely to receive a clinical diagnosis of an eating disorder from a health care practitioner as t [....] » Read More
Title : Patient reported outcomes of GLP 1/GIP agonist use for lipedema: Results from a survey based study
Jesse Cochrane, Lipedema Foundation, United States
Lipedema is a chronic condition characterized by disproportionate fat accumulation, inflammation, and pain, predominantly affecting women. Traditional treatments focus on symptom management, but emerging therapies, such as GLP-1/GIP receptor agonists like semaglutide and tirzepat [....] » Read More